-
Jan 15, 2022 17:55 Source: BSE
Vivo Biotech - Shareholding for the Period Ended December 31, 2021
Vivo Bio Tech Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click here
-
Jan 12, 2022 18:01 Source: BSE
Vivo Biotech - Statement Of Investor Complaints For The Quarter Ended December 2021
| No.of Investor complaints pending at the beginning of the quarter | No.of Investor complaints received during the quarter | No.of Investor complaints disposed of during the quarter | No.of Investor complaints unresolved at the end of the quarter |
|---|
| 0 | 0 | 0 | 0 |
| Name of the Signatory | :- | A KARTHIK |
| Designation | :- | Company Secretary and Compliance Officer |
-
Jan 07, 2022 20:43 Source: BSE
Vivo Biotech - Submission Of Voting Results Along With Scrutinizer''s Report In Respect To The Postal Ballot Notice Dated 2Nd December, 2021
Pursuant to Regulation 44 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 please find enclosed Voting Results along with Scrutinizer''s Report in respect to the Postal Ballot Notice dated 2nd December, 2021.
-
Dec 02, 2021 19:45 Source: BSE
Vivo Biotech - Board Meeting Outcome for Outcome Of Board Meeting Held On 2Nd December, 2021
Please find attached Outcome of Board Meeting.
-
Nov 05, 2021 14:34 Source: BSE
Vivo Biotech - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed the copies of advertisement issued in newspapers on 4th November, 2021 in 'Financial Express' in English Language and in 'Nava Telangana' in Telugu Language, with respect to publication of Un-Audited Consolidated Financial Results for the second quarter and half year ended 30th September, 2021.
-
Nov 02, 2021 20:17 Source: BSE
Vivo Biotech - Announcement under Regulation 30 (LODR)-Change in Directorate
Please find attached disclosure regarding resignation of Mr. K.T.V. Kaladhar (DIN: 08450361), to the office of Director & CFO of the Company and appointment of Mr. K. Sri Kalyan (DIN: 03137506) as an Additional Director (Whole Time Director) of the Company for a period of 5 (five) years with effect from Wednesday, i.e. 3rd November, 2021.
-
Nov 02, 2021 20:13 Source: BSE
Vivo Biotech - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
Please find attached the disclosure under regulation 30 of SEBI (LODR) Regulations, 2015 regarding the resignation of Mr. K.T.V. Kaladhar (DIN: 08450361), to the office of Director & CFO of the Company with effect from Wednesday, i.e. 3rd November, 2021 due to personal reasons.
-
Nov 02, 2021 20:07 Source: BSE
Vivo Biotech - Authorization Of KMP''s Under Regulation 30(5) Of SEBI (LODR) Regulations,2015
Please find attached disclosure under regulation 30 (5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
-
Nov 02, 2021 20:02 Source: BSE
Vivo Biotech - Submission Of Un-Audited Financial Results Along With Limited Review Reports For The Quarter Ended 30Th September, 2021
Please find enclosed herewith the following documents in terms of Regulation 33 of SEBI (LODR) Regulations, 2015: 1. Un-Audited Standalone and Consolidated Financial Results for the Second quarter and half year ended 30th September, 2021. 2. Limited Review Reports on Standalone and Consolidated Financial Results for the Second quarter and half year ended 30th September, 2021 issued by the Statutory Auditor.
-
Nov 02, 2021 19:48 Source: BSE
Vivo Biotech - Board Meeting Outcome for Outcome Of Board Meeting Held On 2Nd November, 2021
Please find attached outcome of the Board Meeting.
